CLINICAL_TRIALS
trial_result
· 2026-01-16
Clinical Trial Update: Intranasal Ketorolac Trial [Phase 2]
Summary
A Phase 2 trial evaluating intranasal ketorolac for headache and migraine has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Washington University School of Medicine | Conditions: Headache, Migraine | Phase 2 | Status: TERMINATED